# Huangshan Tianmu Mint Pharmaceutical

subsidiary of the listed Tianmu Pharmaceutical group; received a renewed drug-manufacturing license from the Anhui Provincial Drug Administration (valid through December 31, 2030) covering raw-material-drug production of menthol and mint-sucrose oil.

Source: https://en.bioecon.ru/companies/huangshan-tianmu-mint-pharmaceutical/
Updated: 2026-07-21

- Country: China

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | CNY 50 million in funding expected from Hangzhou TianMuShan Pharmaceutical Enterprise Co., Ltd. (2025-03-11) | https://www.marketscreener.com/quote/stock/HANGZHOU-TIANMUSHAN-PHARM-9950154/news/Huangshan-Tianmu-Pharmaceutical-Co-Ltd-announced-that-it-expects-to-receive-CNY-50-million-in-fun-49292553/ |
| Regulatory approval | Received renewed drug-manufacturing license from the Anhui Provincial Drug Administration, valid through 2030-12-31 (2025-10-24) | https://www.yaopinnet.com/c1/d8232i.htm |
| Certification | GMP certification (Certificate No. 皖H0198) for menthol and peppermint oil production lines (2007-01-22) | https://www.yaopinnet.com/c1/d8232i.htm |
| Production site | No. 1, Jiulong Avenue, Huangshan Jiulong Low Carbon Economic Park, Tunxi District, Huangshan City, Anhui Province (2006-12) | https://www.yaopinnet.com/c1/d8232i.htm |
| Capacity | Annual processing capacity of 600 tons of raw oil, producing 330 tons of menthol and 240 tons of peppermint oil (2006-12) | https://www.yaopinnet.com/c1/d8232i.htm |

Independent sources: marketscreener.com, yaopinnet.com

## Technologies

- [Biosynthetic menthol](https://en.bioecon.ru/technology/biosynthetic-menthol/)